[DPHARMA] QoQ TTM Result on 31-Dec-2018 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-Feb-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Dec-2018 [#4]
Profit Trend
QoQ- 5.52%
YoY- 12.44%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 554,341 537,324 515,849 498,722 495,341 484,882 477,940 10.38%
PBT 74,528 70,598 65,197 59,666 54,833 53,202 52,929 25.60%
Tax -16,919 -15,562 -13,738 -12,025 -9,793 -9,321 -9,746 44.39%
NP 57,609 55,036 51,459 47,641 45,040 43,881 43,183 21.16%
-
NP to SH 57,609 55,036 51,459 47,776 45,277 44,396 43,710 20.18%
-
Tax Rate 22.70% 22.04% 21.07% 20.15% 17.86% 17.52% 18.41% -
Total Cost 496,732 482,288 464,390 451,081 450,301 441,001 434,757 9.28%
-
Net Worth 505,919 503,029 496,410 483,173 501,487 209,983 206,429 81.67%
Dividend
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Div 33,094 33,094 30,674 30,674 20,937 20,937 23,711 24.86%
Div Payout % 57.45% 60.13% 59.61% 64.21% 46.24% 47.16% 54.25% -
Equity
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Net Worth 505,919 503,029 496,410 483,173 501,487 209,983 206,429 81.67%
NOSH 680,106 661,881 661,881 661,881 661,881 650,902 278,959 81.04%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin 10.39% 10.24% 9.98% 9.55% 9.09% 9.05% 9.04% -
ROE 11.39% 10.94% 10.37% 9.89% 9.03% 21.14% 21.17% -
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 82.18 81.18 77.94 75.35 75.07 173.19 171.33 -38.69%
EPS 8.54 8.32 7.77 7.22 6.86 15.86 15.67 -33.25%
DPS 5.00 5.00 4.63 4.63 3.17 7.50 8.50 -29.77%
NAPS 0.75 0.76 0.75 0.73 0.76 0.75 0.74 0.89%
Adjusted Per Share Value based on latest NOSH - 661,881
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 57.63 55.86 53.63 51.85 51.49 50.41 49.68 10.39%
EPS 5.99 5.72 5.35 4.97 4.71 4.62 4.54 20.27%
DPS 3.44 3.44 3.19 3.19 2.18 2.18 2.46 25.02%
NAPS 0.5259 0.5229 0.5161 0.5023 0.5213 0.2183 0.2146 81.66%
Price Multiplier on Financial Quarter End Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 -
Price 1.40 1.37 1.28 0.95 1.23 1.30 2.80 -
P/RPS 1.70 1.69 1.64 1.26 1.64 0.75 1.63 2.84%
P/EPS 16.39 16.48 16.46 13.16 17.93 8.20 17.87 -5.59%
EY 6.10 6.07 6.07 7.60 5.58 12.20 5.60 5.86%
DY 3.57 3.65 3.62 4.88 2.58 5.77 3.04 11.29%
P/NAPS 1.87 1.80 1.71 1.30 1.62 1.73 3.78 -37.42%
Price Multiplier on Announcement Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 29/11/19 30/08/19 21/05/19 18/02/19 28/11/18 26/11/18 28/05/18 -
Price 1.39 1.41 1.36 1.03 1.07 1.08 3.35 -
P/RPS 1.69 1.74 1.75 1.37 1.43 0.62 1.96 -9.40%
P/EPS 16.28 16.96 17.49 14.27 15.59 6.81 21.38 -16.59%
EY 6.14 5.90 5.72 7.01 6.41 14.68 4.68 19.82%
DY 3.60 3.55 3.41 4.50 2.97 6.94 2.54 26.14%
P/NAPS 1.85 1.86 1.81 1.41 1.41 1.44 4.53 -44.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment